CGM Device for Diabetes
(Salud Diabetes Trial)
Trial Summary
What is the purpose of this trial?
The aim of this proposal is to determine the impact of a produce prescription program in predominantly Hispanic/Latino adults with established non-insulin treated T2D and an HbA1c at or above 9%.
Research Team
David Kerr, PhD
Principal Investigator
Sutter Health
Eligibility Criteria
This trial is for Hispanic/Latino adults with Type 2 Diabetes not treated with insulin and an HbA1c level at or above 9%. The study focuses on the effects of a produce prescription program.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a produce prescription program, with some randomized to also receive real-time continuous glucose monitoring (rtCGM) for 3 months
Follow-up
Participants are monitored for changes in HbA1c, body weight, waist circumference, blood pressure, and mental health using DASS-21
Treatment Details
Interventions
- CGM Device
- Salud Diabetes
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sutter Health
Lead Sponsor
William Marsh Rice University
Collaborator